Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biomea Fusion, Inc. - Common Stock (NQ:BMEA)

1.670 +0.020 (+1.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,642,114
Open 1.630
Bid (Size) 1.660 (5)
Ask (Size) 1.670 (69)
Prev. Close 1.650
Today's Range 1.571 - 1.680
52wk Range 1.290 - 12.85
Shares Outstanding 35,631,576
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top stock movements in today's session.
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga

Performance

YTD
-54.7%
-54.7%
1 Month
-14.8%
-14.8%
3 Month
-13.9%
-13.9%
6 Month
+3.1%
+3.1%
1 Year
-84.0%
-84.0%

More News

Read More
Which stocks are moving on Tuesday?
Via Chartmill
Biomea Fusion Stock Plummets Following Public Offering, Diabetes Study
Via Benzinga
Tuesday's session: gap up and gap down stocks
Via Chartmill
Dow Jumps Over 100 Points; McCormick Earnings Top Views
Via Benzinga
Topics Stocks
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Biomea Fusion Announces Pricing of Public Offering of Securities
From Biomea Fusion, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Biomea Fusion Announces Proposed Public Offering of Securities
From Biomea Fusion, Inc.
Via GlobeNewswire
Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations
From Biomea Fusion, Inc.
Via GlobeNewswire
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Biomea Fusion, Inc.
Via GlobeNewswire
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update
From Biomea Fusion, Inc.
Via GlobeNewswire
This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Biomea Fusion (BMEA) Q2 Loss Drops 44%
Via The Motley Fool
Topics Intellectual Property
Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights
From Biomea Fusion, Inc.
Via GlobeNewswire
Biomea Fusion Appoints Julianne Averill to its Board of Directors
From Biomea Fusion, Inc.
Via GlobeNewswire
These stocks are moving in today's after hours session
Via Chartmill
Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)
From Biomea Fusion, Inc.
Via GlobeNewswire
Which stocks are experiencing notable movement on Wednesday?
Via Chartmill
Crude Oil Moves Higher; US Weekly Jobless Claims Decline
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Here are the top movers in Wednesday's session.
Via Chartmill
Which stocks are gapping on Wednesday?
Via Chartmill

Frequently Asked Questions

Is Biomea Fusion, Inc. - Common Stock publicly traded?
Yes, Biomea Fusion, Inc. - Common Stock is publicly traded.
What exchange does Biomea Fusion, Inc. - Common Stock trade on?
Biomea Fusion, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Biomea Fusion, Inc. - Common Stock?
The ticker symbol for Biomea Fusion, Inc. - Common Stock is BMEA on the Nasdaq Stock Market
What is the current price of Biomea Fusion, Inc. - Common Stock?
The current price of Biomea Fusion, Inc. - Common Stock is 1.670
When was Biomea Fusion, Inc. - Common Stock last traded?
The last trade of Biomea Fusion, Inc. - Common Stock was at 10/14/25 04:00 PM ET
What is the market capitalization of Biomea Fusion, Inc. - Common Stock?
The market capitalization of Biomea Fusion, Inc. - Common Stock is 59.50M
How many shares of Biomea Fusion, Inc. - Common Stock are outstanding?
Biomea Fusion, Inc. - Common Stock has 60M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.